of intangible assets: (a) the useful lives or the amortisation rates used and the reasons for choosing those periods; (b) the amortisation methods used; (c) the gross carrying amount and any accumulated amortisation (aggregated with accumulated impairment losses) at the beginning and end of the reporting period; the line item(s) in the statement of comprehensive income (or in the income statement, if presented) in which any amortisation of intangible assets is included; and (e) a reconciliation of the carrying amount at the beginning and end of the reporting period showing separately: additions, indicating separately those from internal development and those acquired separately; disposals; acquisitions through business combinations; revaluations; amortisation; impairment losses recognised or reversed in profit or loss in accordance with Section 27 Impairment of Assets; and other changes. This reconciliation need not be presented for prior periods. An entity shall also disclose: a description, the carrying amount and remaining amortisation period of any individual intangible asset that is material to the entityâ€™s financial statements; for intangible assets acquired by way of a grant and initially recognised at fair value (see paragraph 18.12): the fair value initially recognised for these assets; and their carrying amounts. (c) the existence and carrying amounts of intangible assets to which the entity has restricted title or that are pledged as security for liabilities; and (d) the amount of contractual commitments for the acquisition of intangible assets. A When, as part of a business combination, an acquirer chooses to recognise intangible assets separately from goodwill that meet condition (a) and only one of (b) or (c) in paragraph 18.8, the acquirer shall disclose the nature of those intangible assets and the reason why they have been separated from goodwill. An entity shall disclose the aggregate amount of research and development expenditure recognised as an expense